{"nct_id":"NCT04810078","title":"A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-10","start_date":"2021-05-21","start_date_type":"ACTUAL","primary_completion_date":"2025-07-29","primary_completion_date_type":"ACTUAL","completion_date":"2027-05-10","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["BMY"]}